Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN110437212A reveals efficient copper-catalyzed synthesis. Delivers high-purity intermediates with substantial cost reduction and supply chain reliability.
Novel patent CN106957239A offers low-cost Lacosamide synthesis. High yield, mild conditions, scalable for reliable pharmaceutical intermediate supply chains.
Patent CN108822086A details high-purity purification. Enhances supply chain reliability and reduces manufacturing costs for pharmaceutical intermediates.
Patent CN102206185A reveals a dual-solvent recrystallization method achieving >99.6% purity and <0.2% impurities for cataract drug intermediates.
Novel silylation reagent improves pasireotide intermediate yield significantly. Reduces costs and enhances supply chain reliability for pharmaceutical manufacturing partners globally.
Patent CN106631898A details a rhodium-catalyzed amidine synthesis offering high purity and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN110437275A reveals a high-purity Choline Glycerophosphate synthesis route offering significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel NaBH4/TFA reduction route improves yield to 80% and purity, offering significant cost reduction in API manufacturing.
Patent CN108137637B reveals a novel ruthenium complex production method with superior atom efficiency, offering cost reduction in pharmaceutical intermediates manufacturing.
Patent CN117567404B reveals a novel synthesis route for pharmaceutical intermediates. Achieve high purity and cost reduction in API manufacturing with scalable methods.
Patent CN118125897A reveals a room-temperature visible-light method for Z-selective monofluoroolefin synthesis, offering significant cost and supply chain advantages for pharmaceutical manufacturing.
Patent CN112047865B details a green aqueous synthesis of N-alkylsulfonamides using Cp*Ir catalysts, offering cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN116003407A reveals a scalable Zolpidem synthesis using PBr3-Lewis Acid catalysis, offering high purity and cost reduction in pharmaceutical intermediates manufacturing.
Novel Ni-catalyzed alpha-butenylation of ketones with 1,3-butadiene. High yield, atom-economic route for API intermediates. Cost-effective supply chain solution.
Patent CN1314685C reveals a high-yield synthesis of 2,6-dihalopurine using halosilanes. Discover cost-effective manufacturing and scalable supply chain solutions for nucleoside analogs.
Patent CN106243018B reveals nickel-catalyzed route for PIM447 intermediates. Offers cost reduction and scalable manufacturing for pharmaceutical supply chains globally.
Patent CN106243018B enables nickel-catalyzed synthesis of polyfluorophenylpyridine intermediates. Reduces cost and improves supply chain reliability for pharmaceutical manufacturing partners globally.
Patent CN104447451A reveals safer Oseltamivir intermediate synthesis avoiding sodium azide. Enhances supply chain reliability and reduces manufacturing costs significantly.
Patent CN112851574A reveals a novel low-temperature acetonitrile process for synthesizing high-purity sodium picosulfate intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Advanced synthesis of Empagliflozin intermediates via novel Grignard reduction. Superior isomer control and scalable manufacturing for global pharmaceutical supply chains.